ESTIBIO ApS: Financial statements 2022
CVR: 29211663
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
ESTIBIO ApS (CVR 29211663) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -64,926 and a net result of DKK 4,682,831 compared with DKK -449,903 the year before. Equity in the 2022 report amounted to DKK -86,029.
- Gross Profit
- DKK -64,926
- Profit/Loss
- DKK 4,682,831
- Equity
- DKK -86,029
- Total Assets
- DKK 5,051
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -65 t. | 4.7 mio. | -86 t. | - |
| 2021 | - | -50 t. | -450 t. | -4.8 mio. | - |
| 2020 | - | -88 t. | -461 t. | -4.3 mio. | - |
| 2019 | - | -97 t. | -447 t. | -3.9 mio. | - |
| 2018 | - | -114 t. | -432 t. | -3.4 mio. | - |
Official annual report
Keep an eye on ESTIBIO ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
ESTIBIO ApS has published its annual report for 2021. Gross profit came to DKK -49,611, and the net result was DKK -449,903.
About ESTIBIO ApS
ESTIBIO ApS was a Danish company of the type Anpartsselskab based in Ballerup, founded in 2005. The company has been dissolved on 20 March 2024. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 0 employees (2014). In 2022, the company reported a gross profit of DKK -64,926 and a net result of DKK 4,682,831 compared with DKK -449,903 the year before. Equity in the 2022 report amounted to DKK -86,029.